NIH granted Nanokide

The NCL has selected our technology Span-based nanoparticles loaded with miR-20a for the preclinical development program

Read More

Toribio Echevarria Awards

Nanokide awarded as finalist in the Business Ideas/Projects section of the Toribio Echevarria 2022 awards.

Read More

Cantábrico Excelente Awards

Nanokide Therapeutics awarded in the category of best R+D+i company in the VI edition of the Cantabrian Excellent Awards.

Read More

"Our nanoparticle blocks tumor growth"

Interview in the newspaper Berria

Read More

Nanokide in B-Venture 2022

Nanokid Therapeutics participated in B-Venture 2022 in Bilbao from 18th to 19th of October

Read More